Yiling Pharmaceutical’s new Chinese medicine Lianhua Qingke tablets approved in China

On May 14, Lianhua Qingke Tablets, a new class 6.1 Chinese medicine declared by Yiling Pharmaceutical, was approved by the State Food and Drug Administration for market entry.

On May 14, Lianhua Qingke Tablets, a new class 6.1 Chinese medicine declared by Yiling Pharmaceutical, was approved by the State Food and Drug Administration for market entry.

It is used to treat acute trachea and bronchitis.

Lianhua Qingke Tablets is another innovative Chinese medicine developed by Yiling Pharmaceutical Co., Ltd., on acute bronchitis, a common respiratory disease, following Lianhua Qingwen capsules.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/05/15/yiling-pharmaceutical-s-new-chinese-medicine-lianhua-qingke-tablets-approved-in-china/.

Leave a Reply

Please Login to Comment